JPMorgan Chase & Co. Sells 23,068 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)
JPMorgan Chase & Co. trimmed its position in Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 14.2% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 139,581 shares of the company’s stock after selling 23,068 shares during the period. JPMorgan Chase & Co.’s holdings in Summit Therapeutics were worth $2,491,000 at the end of […]
JPMorgan Chase & Co. trimmed its position in Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 14.2% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 139,581 shares of the company’s stock after selling 23,068 shares during the period. JPMorgan Chase & Co.’s holdings in Summit Therapeutics were worth $2,491,000 at the end of […]
